Early treatment with tirofiban improves outcomes in patients with STEMI

  • Published 2008 in Nature Clinical Practice Cardiovascular Medicine

Abstract

two treatment groups was evident in relation to troponin I release (P = 0.15). In a small subgroup of 27 patients the absolute mass of the area of hyperenhancement on cardiac MRI was significantly reduced in cyclosproin-treated patients compared with those who received placebo (37 g versus 46 g, P = 0.04). Cyclosporine treatment was not associated with any adverse events. The authors concluded that these promising data require validation in a large, clinical trial.

DOI: 10.1038/ncpcardio1391

Cite this paper

@article{2008EarlyTW, title={Early treatment with tirofiban improves outcomes in patients with STEMI}, author={}, journal={Nature Clinical Practice Cardiovascular Medicine}, year={2008}, volume={5}, pages={751-751} }